Expression of eukaryotic initiation factor 4E and 4E binding protein 1 in colorectal carcinogenesis
- PMID: 25755728
- PMCID: PMC4348849
Expression of eukaryotic initiation factor 4E and 4E binding protein 1 in colorectal carcinogenesis
Abstract
Cap dependent translation is mainly regulated at the level of the eukaryotic initiation factor 4E (eIF4E), the activity of which is controlled by phosphorylation and sequestration by its well established regulator, 4E binding protein 1 (4E-BP1). Both eIF4E and 4E-BP1 have been shown to be involved in the malignant progression of multiple human cancers, including colorectal cancer. However, the data on determining the expression of eIF4E, 4E-BP1 and their phosphorylated forms simultaneously in a single patient with colorectal cancer is lacking. Therefore the aim of our study was to explore the roles of these factors in colorectal carcinogenesis by immunohistostaining colorectal tissues (normal, low grade adenoma, high grade adenoma, and adenocarcinoma). Our results showed that the expression levels of eIF4E increased steadily as the cancer progressed from the case of benign dysplasia to an adenocarcinoma; all the while maintaining an unphosphorylated form. On the other hand, total expression levels of 4E-BP1 increased only in the premalignant state of the disease and decreased (but highly phosphorylated or inactivated) or abolished upon malignancy. Taken together, our findings suggest that strong correlations exist between the expression of eIF4E (not p-eIF4E) and tumor grade providing evidence that eIF4E expression plays a pivotal role in the malignant progression of colorectal cancer. Moreover, 4E-BP1 showed a bi-phasic level of expression during carcinogenesis, which is expressed only in hyperplasic or dysplastic tissues as an endogenous tumor suppressor molecule.
Keywords: 4E-BP1; Colorectal cancer; eIF4E; immunuhistochemistry; translational control.
Figures




Similar articles
-
Putative role of the mTOR/4E-BP1 signaling pathway in the carcinogenesis and progression of gastric cardiac adenocarcinoma.Mol Med Rep. 2013 Feb;7(2):537-42. doi: 10.3892/mmr.2012.1208. Epub 2012 Nov 28. Mol Med Rep. 2013. PMID: 23229050
-
Eukaryotic translation initiation factor 4E (eIF-4E) expressions are associated with poor prognosis in colorectal adenocarcinoma.Pathol Res Pract. 2017 May;213(5):490-495. doi: 10.1016/j.prp.2017.02.004. Epub 2017 Feb 14. Pathol Res Pract. 2017. PMID: 28242042
-
Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer.Clin Biochem. 2006 Apr;39(4):404-9. doi: 10.1016/j.clinbiochem.2005.11.007. Epub 2005 Dec 20. Clin Biochem. 2006. PMID: 16375881
-
Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis.Oncogene. 2016 Sep 8;35(36):4675-88. doi: 10.1038/onc.2015.515. Epub 2016 Feb 1. Oncogene. 2016. PMID: 26829052 Review.
-
The intra-tumor heterogeneity of cell signaling factors in breast cancer: p4E-BP1 and peIF4E are diffusely expressed and are real potential targets.Clin Transl Oncol. 2014 Nov;16(11):937-41. doi: 10.1007/s12094-014-1203-9. Epub 2014 Jul 25. Clin Transl Oncol. 2014. PMID: 25060567 Review.
Cited by
-
Identification of Gene Signature as Diagnostic and Prognostic Blood Biomarker for Early Hepatocellular Carcinoma Using Integrated Cross-Species Transcriptomic and Network Analyses.Front Genet. 2021 Sep 29;12:710049. doi: 10.3389/fgene.2021.710049. eCollection 2021. Front Genet. 2021. PMID: 34659334 Free PMC article.
-
Overexpression of eIF4E in colorectal cancer patients is associated with liver metastasis.Onco Targets Ther. 2016 Feb 19;9:815-22. doi: 10.2147/OTT.S98330. eCollection 2016. Onco Targets Ther. 2016. PMID: 26929650 Free PMC article.
-
Prevalence of programmed death-1 ligand-1 (PD-L1) and infiltrating lymphocytes in human gastric carcinogenesis.Int J Clin Exp Pathol. 2017 Dec 1;10(12):11754-11759. eCollection 2017. Int J Clin Exp Pathol. 2017. PMID: 31966537 Free PMC article.
-
Clinical Significance of Eukaryotic Initiation Factor 4E (eIF4E) Level among Cases Suffering Basal Cell Carcinoma of Skin.Med Sci Monit. 2019 Oct 23;25:7936-7941. doi: 10.12659/MSM.917679. Med Sci Monit. 2019. PMID: 31641096 Free PMC article.
-
Prognostic significance of eukaryotic initiation factor 4E in hepatocellular carcinoma.J Cancer Res Clin Oncol. 2016 Nov;142(11):2309-17. doi: 10.1007/s00432-016-2232-2. Epub 2016 Sep 6. J Cancer Res Clin Oncol. 2016. PMID: 27601163 Free PMC article.
References
-
- Siegel R, Desantis C, Jemal A. Colorectal cancer statistics 2014. CA Cancer J Clin. 2014;64:104–117. - PubMed
-
- Martineau Y, Azar R, Bousquet C, Pyronnet S. Anti-oncogenic potential of the eIF4E-binding proteins. Oncogene. 2013;32:671–6777. - PubMed
-
- Avdulov S, Li S, Michalek V, Burrichter D, Peterson M, Perlman DM, Manivel JC, Sonenberg N, Yee D, Bitterman PB, Polunovsky VA. Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. Cancer Cell. 2004;5:553–563. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous